Empiric intravenous fluid and electrolyte therapy in patients with Ebola virus disease

Tropical Doctor

Volumn 46, Issue 3, 2016, Pages 148-150

  Hunt, Luke ^a   Lee, James S ^b  

^a LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

clinical care; Ebola; Ebola virus disease; electrolyte replacement; intravenous fluid therapy

Indexed keywords

ASPARTATE AMINOTRANSFERASE; CREATINE KINASE; CREATININE; ELECTROLYTE; GLUCOSE; POTASSIUM; SODIUM CHLORIDE;

ACUTE KIDNEY FAILURE; ARTICLE; CLINICAL FEATURE; DIARRHEA; DISEASE COURSE; EBOLA HEMORRHAGIC FEVER; ELECTROLYTE DISTURBANCE; FLUID THERAPY; GASTROINTESTINAL HEMORRHAGE; HUMAN; HYPERKALEMIA; HYPONATREMIA; HYPOVOLEMIA; INFLAMMATION; MULTIPLE ORGAN FAILURE; PATIENT CARE; RISK FACTOR; VIRUS LOAD; EPIDEMIC; HEMORRHAGIC FEVER, EBOLA; PROCEDURES; SIERRA LEONE; TREATMENT OUTCOME;

DISEASE OUTBREAKS; ELECTROLYTES; FLUID THERAPY; HEMORRHAGIC FEVER, EBOLA; HUMANS; SIERRA LEONE; TREATMENT OUTCOME;

EID: 84977547707     PISSN: 00494755     EISSN: 17581133     Source Type: Journal    
DOI: 10.1177/0049475516644883     Document Type: Article

References (8)

1. L.HuntA.Gupta-WrightV.Simms. Clinical presentation, biochemical, and haematological parameters and their association with outcome in patients with Ebola virus disease: an observational cohort study. Lancet Infect Dis2015; 15: 1292–1299.
2. K.ClayA.M.JohnstonA.Moore. Targeted electrolyte replacement in patients with Ebola virus disease. Clin Infect Dis2015; 61: 1030–1031.
3. E.QinJ.BiM.Zhao. Clinical features of patients with Ebola virus disease in Sierra Leone. Clin Infect Dis2015; 61: 491–495.
4. D.S.ChertowC.KleineJ.K.Edwards. Ebola virus disease in West Africa—clinical manifestations and management. New Engl J Med2014; 371: 2054–2057.
5. E.I.BahM.C.LamahT.Fletcher. Clinical presentation of patients with Ebola virus disease in Conakry, Guinea. New Engl J Med2015; 372: 40–47.
6. WHO Ebola Response Team. Ebola virus disease in West Africa—the first 9 months of the epidemic and forward projections. New Engl J Med2014; 371: 1481–1495.
7. T.E.FletcherR.A.FowlerN.J.Beeching. Understanding organ dysfunction in Ebola virus disease. Intensive Care Med2014; 40: 1936–1939.
8. A.SanchezM.LukwiyaD.Bausch. Analysis of human peripheral blood samples from fatal and nonfatal cases of Ebola (Sudan) hemorrhagic fever: cellular responses, virus load, and nitric oxide levels. J Virol2004; 78: 10370–10377.